Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection

• Status: Completed
• Trial end date: 2009-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Patients will be enrolled in a multi-center study (Wilford Hall Medical Center and Brooke Army Medical Center) to prospectively evaluate outcome after treatment for an uncomplicated skin abscess.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: 59th Medical Wing; Wilford Hall Medical Center
• Collaborators: Emergency Medicine Foundation; U.S. Air Force Office of the Surgeon General
• Treatments: Methicillin; Trimethoprim, Sulfamethoxazole Drug Combination

Criteria

Inclusion Criteria:

• All patients age 18-65 who present to the emergency department with a skin abscess that requires incision and drainage.

Exclusion Criteria:

• Patients with diabetes, HIV, cancer or other immunocompromised patients.

• Additionally, any patients who received antibiotics within one week of presentation or were hospitalized in previous month will be excluded to minimize potential confounding variables.

• Pregnant and breastfeeding patients will also be excluded due to possible safety concerns with antibiotic treatment.

• Patients with abscesses on head, face, perirectal, or periananal regions, abscesses with known tracks or fistulas to deeper structures, or abscesses requiring surgical drainage in an operating room are excluded.

• Finally, patients with sulfa allergy will be excluded.